Long-Term Extension of a Dose Finding Study to Evaluate the Safety, Efficacy, and Tolerability of Multiple Doses of rAvPAL-PEG in Subjects With Phenylketonuria (PKU) (PAL-003)
This study is enrolling participants by invitation only.
Study NCT00924703
Information provided by BioMarin Pharmaceutical
First Received on June 18, 2009.
Last Updated on June 13, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
